America’s Food and Drug Administration approved a medication produced by Eli Lilly, a pharmaceutical firm, for weight-loss use. The injectable, called Zepbound, is part of a new generation of obesity drugs, and has the same active ingredient as Mounjaro, which is already approved to treat diabetes. It will compete against Novo Nordisk’s Wegovy, the weight-loss version of Ozempic.
- Forums
- ASX - By Stock
- RMD
- Buy RMD now and get great upside returns in a year or two
Buy RMD now and get great upside returns in a year or two, page-5
-
- There are more pages in this discussion • 193 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add RMD (ASX) to my watchlist
|
|||||
Last
$31.89 |
Change
0.160(0.50%) |
Mkt cap ! $20.24B |
Open | High | Low | Value | Volume |
$31.57 | $31.91 | $31.55 | $26.14M | 821.3K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 155 | $31.88 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$31.90 | 8959 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
3 | 1872 | 33.480 |
1 | 259 | 32.650 |
1 | 31 | 32.000 |
2 | 17 | 31.800 |
1 | 223 | 31.750 |
Price($) | Vol. | No. |
---|---|---|
30.300 | 382 | 1 |
30.750 | 33 | 1 |
31.200 | 58 | 2 |
31.250 | 596 | 1 |
31.950 | 354 | 3 |
Last trade - 16.10pm 13/06/2024 (20 minute delay) ? |
|
|||||
Last
$31.88 |
  |
Change
0.160 ( 0.25 %) |
|||
Open | High | Low | Volume | ||
$31.57 | $31.91 | $31.57 | 243046 | ||
Last updated 15.59pm 13/06/2024 ? |
Featured News
RMD (ASX) Chart |